Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020-Reference-Cited by-同舟云学术

Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020

Published:2022-12-13 Issue:1 Volume:201 Page:64-74
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Harmanen Minna¹^ORCID,Hujo Mika²,Sund Reijo³,Sorigue Marc⁴,Khan Madiha¹,Prusila Roosa⁵^ORCID,Klaavuniemi Tuula⁶,Kari Esa⁷,Jantunen Esa⁸⁹,Sunela Kaisa⁷^ORCID,Rajamäki Aino¹⁰¹¹^ORCID,Alanne Erika¹²,Kuitunen Hanne¹³^ORCID,Sancho Juan‐Manuel⁴^ORCID,Jukkola Arja⁷^ORCID,Rönkä Aino¹⁴,Kuittinen Outi¹⁴^ORCID

Affiliation:

1. Oncology, Faculty of Health Medicine, School of Medicine Institute of Clinical Medicine, University of Eastern Finland Kuopio Finland

2. Statistics, Faculty of Science and Forestry, School of Computing University of Eastern Finland Kuopio Finland

3. Faculty of Health Medicine, School of Medicine, Institute of Clinical Medicine University of Eastern Finland Kuopio Finland

4. Department of Hematology ICO‐Badalona, Hospital Germans Trias i Pujol, IJC Badalona Spain

5. Medical Research Centre and Cancer and Translational Research Unit University of Oulu and Oulu University Hospital Oulu Finland

6. Department of Oncology Mikkeli Central Hospital Mikkeli Finland

7. Department of Oncology Tampere University Hospital, Tampere Cancer Center, Faculty of Medicine and Health Technology, Tampere University Tampere Finland

8. Department of Medicine Hospital District of North Carelia, Institute of Clinical Medicine/Internal Medicine, University of Eastern Finland Kuopio Finland

9. Department of Medicine Kuopio University Hospital Kuopio Finland

10. Department of Oncology Hospital Nova of Central Finland Jyväskylä Finland

11. Faculty of Health Medicine, School of Medicine Institute of Clinical Medicine, University of Eastern Finland Kuopio Finland

12. Department of Oncology and Radiotherapy Turku University Hospital, Western Finland Cancer Centre Turku Finland

13. Medical Research Centre and Cancer and Translational Research Unit, University of Oulu and Oulu University Hospital Oulu Finland

14. Oncology, Faculty of Health Medicine, School of Medicine, Institute of Clinical Medicine, Kuopio University Hospital Department of Oncology University of Eastern Finland Kuopio Finland

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18597

Reference26 articles.

1. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management

2. Cancer statistics[Internet].Syöpärekisteri; 2019. [cited 2022 Jul 5]. Available from:https://cancerregistry.fi/statistics/cancer‐statistics/

3. Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

4. Minimal Residual Disease and Survival Outcomes in Patients with Mantle Cell Lymphoma: a systematic review and meta-analysis

5. A Danish population-based analysis of 105 mantle cell lymphoma patients

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Outcomes of Patients with Mantle Cell Lymphoma: A Retrospective, 15-Year, Real-Life Study;Hematology Reports;2024-01-18

2. Resistance to PRMT5-targeted therapy in mantle cell lymphoma;Blood Advances;2023-12-29

3. Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United Kingdom;British Journal of Haematology;2023-10-30

4. Do CAR-T and Allogeneic Stem Cell Transplant Both Have a Place in Lymphoid Neoplasms?;International Journal of Molecular Sciences;2023-01-05

5. Treatment outcomes of mantle cell lymphoma in real-world practice: analysis of forty-one patients;Journal of Clinical and Experimental Hematopathology;2023